Found 6 hits for monomerid = 50303854 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Fructose-1,6-bisphosphatase 1 (FBPase)
(Homo sapiens (Human)) | BDBM50303854
(5-(4-amino-7-ethyl-5-fluoro-1-isobutyl-1H-benzo[d]...)Show SMILES CCc1cc(F)c(N)c2nc(-c3ccc(o3)P(O)(O)=O)n(CC(C)C)c12 Show InChI InChI=1S/C17H21FN3O4P/c1-4-10-7-11(18)14(19)15-16(10)21(8-9(2)3)17(20-15)12-5-6-13(25-12)26(22,23)24/h5-7,9H,4,8,19H2,1-3H3,(H2,22,23,24) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabasis Therapeutics, Inc.
Curated by ChEMBL
| Assay Description Inhibition of human liver FBPase 1 |
J Med Chem 53: 441-51 (2010)
Article DOI: 10.1021/jm901420x BindingDB Entry DOI: 10.7270/Q2N58MFJ |
More data for this Ligand-Target Pair | |
Adenosine kinase
(Homo sapiens (Human)) | BDBM50303854
(5-(4-amino-7-ethyl-5-fluoro-1-isobutyl-1H-benzo[d]...)Show SMILES CCc1cc(F)c(N)c2nc(-c3ccc(o3)P(O)(O)=O)n(CC(C)C)c12 Show InChI InChI=1S/C17H21FN3O4P/c1-4-10-7-11(18)14(19)15-16(10)21(8-9(2)3)17(20-15)12-5-6-13(25-12)26(22,23)24/h5-7,9H,4,8,19H2,1-3H3,(H2,22,23,24) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabasis Therapeutics, Inc.
Curated by ChEMBL
| Assay Description Inhibition of adenosine kinase AMP binding site |
J Med Chem 53: 441-51 (2010)
Article DOI: 10.1021/jm901420x BindingDB Entry DOI: 10.7270/Q2N58MFJ |
More data for this Ligand-Target Pair | |
Fructose-1,6-bisphosphatase 1 (FBPase)
(Homo sapiens (Human)) | BDBM50303854
(5-(4-amino-7-ethyl-5-fluoro-1-isobutyl-1H-benzo[d]...)Show SMILES CCc1cc(F)c(N)c2nc(-c3ccc(o3)P(O)(O)=O)n(CC(C)C)c12 Show InChI InChI=1S/C17H21FN3O4P/c1-4-10-7-11(18)14(19)15-16(10)21(8-9(2)3)17(20-15)12-5-6-13(25-12)26(22,23)24/h5-7,9H,4,8,19H2,1-3H3,(H2,22,23,24) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabasis Therapeutics, Inc.
Curated by ChEMBL
| Assay Description Inhibition of human liver FBP |
J Med Chem 54: 153-65 (2011)
Article DOI: 10.1021/jm101035x BindingDB Entry DOI: 10.7270/Q2CN74WJ |
More data for this Ligand-Target Pair | |
Phosphofructokinase muscle type
(Homo sapiens (Human)) | BDBM50303854
(5-(4-amino-7-ethyl-5-fluoro-1-isobutyl-1H-benzo[d]...)Show SMILES CCc1cc(F)c(N)c2nc(-c3ccc(o3)P(O)(O)=O)n(CC(C)C)c12 Show InChI InChI=1S/C17H21FN3O4P/c1-4-10-7-11(18)14(19)15-16(10)21(8-9(2)3)17(20-15)12-5-6-13(25-12)26(22,23)24/h5-7,9H,4,8,19H2,1-3H3,(H2,22,23,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a |
Metabasis Therapeutics, Inc.
Curated by ChEMBL
| Assay Description Inhibition of phosphofructokinase AMP binding site |
J Med Chem 53: 441-51 (2010)
Article DOI: 10.1021/jm901420x BindingDB Entry DOI: 10.7270/Q2N58MFJ |
More data for this Ligand-Target Pair | |
Fructose-1,6-bisphosphatase
(Rattus norvegicus) | BDBM50303854
(5-(4-amino-7-ethyl-5-fluoro-1-isobutyl-1H-benzo[d]...)Show SMILES CCc1cc(F)c(N)c2nc(-c3ccc(o3)P(O)(O)=O)n(CC(C)C)c12 Show InChI InChI=1S/C17H21FN3O4P/c1-4-10-7-11(18)14(19)15-16(10)21(8-9(2)3)17(20-15)12-5-6-13(25-12)26(22,23)24/h5-7,9H,4,8,19H2,1-3H3,(H2,22,23,24) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabasis Therapeutics, Inc.
Curated by ChEMBL
| Assay Description Inhibition of rat liver FBPase 1 |
J Med Chem 53: 441-51 (2010)
Article DOI: 10.1021/jm901420x BindingDB Entry DOI: 10.7270/Q2N58MFJ |
More data for this Ligand-Target Pair | |
Adenosine deaminase
(Homo sapiens (Human)) | BDBM50303854
(5-(4-amino-7-ethyl-5-fluoro-1-isobutyl-1H-benzo[d]...)Show SMILES CCc1cc(F)c(N)c2nc(-c3ccc(o3)P(O)(O)=O)n(CC(C)C)c12 Show InChI InChI=1S/C17H21FN3O4P/c1-4-10-7-11(18)14(19)15-16(10)21(8-9(2)3)17(20-15)12-5-6-13(25-12)26(22,23)24/h5-7,9H,4,8,19H2,1-3H3,(H2,22,23,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabasis Therapeutics, Inc.
Curated by ChEMBL
| Assay Description Inhibition of AMP deaminase AMP binding site |
J Med Chem 53: 441-51 (2010)
Article DOI: 10.1021/jm901420x BindingDB Entry DOI: 10.7270/Q2N58MFJ |
More data for this Ligand-Target Pair | |